This study aims to investigate the expression pattern of CD200 on leukemic B cells and to determine whether CD200 could emerge as a new tool for the detection of B-ALL cases and the incorporation of CD200 into routine MRD panels. This evidence concerns the gene CD200 and precursor B-cell acute lymphoblastic leukemia.